A rationale for the design and synthesis of m1 selective muscarinic agonists.
- 31 August 1992
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 2 (8) , 821-826
- https://doi.org/10.1016/s0960-894x(00)80538-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Synthesis and muscarinic activity of quinuclidinyl- and (1-azanorbornyl)pyrazine derivativesJournal of Medicinal Chemistry, 1992
- Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodiesJournal of Neuroscience, 1991
- Muscarinic cholinergic agonists and antagonists of the 3-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,2,5,6-tetrahydropyridine type. Synthesis and structure-activity relationshipsJournal of Medicinal Chemistry, 1991
- Synthesis and muscarinic activities of 1,2,4-thiadiazolesJournal of Medicinal Chemistry, 1990
- Muscarinic Receptor SubtypesAnnual Review of Pharmacology and Toxicology, 1990
- Muscarinic Receptor SubtypesNew England Journal of Medicine, 1989
- Predicting the biologically conformations of short polypeptidesTrends in Pharmacological Sciences, 1989
- Chapter 4. Central Muscarinic Ligands and ReceptorsPublished by Elsevier ,1989
- Identification of a Family of Muscarinic Acetylcholine Receptor GenesScience, 1987
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982